BNB Surges Over 6% as U.S.-EU Trade Pact Sparks $610M in Corporate Accumulation

BNB Surges Over 6% on $610M Corporate Buying and U.S.–EU Trade Agreement

BNB posted a strong rally on Monday, climbing more than 6.6% in 24 hours amid a spike in institutional demand and optimism surrounding a newly signed trade pact between the United States and the European Union.

The token rose from $796.95 to an intraday high of $860.86 before paring gains slightly to trade near $850. The move was accompanied by a sharp rise in trading volume, which jumped 170%, with over 271,000 BNB changing hands within a single hour—well above average—suggesting large-scale accumulation by strategic players rather than retail-driven speculation.

Market sentiment was further boosted by news of a U.S.–EU trade agreement that helped avert a trade war. The deal introduces a 15% tariff on most EU imports and includes commitments from the bloc to invest in U.S. sectors. It follows a series of trade agreements recently announced by President Donald Trump, including with Japan and Indonesia.

Investor interest in BNB was amplified by substantial corporate treasury allocations. Windtree Therapeutics led the charge with a $520 million investment, followed by Nano Labs, which added $90 million to its BNB holdings. Other firms, including Build and Build Corp, are also reported to be accumulating.

Despite the strong rally, BNB faces technical resistance around $860, a level where some profit-taking has already occurred. Still, the combination of macro tailwinds and institutional inflows could keep upward momentum intact.